Jacobs Bruce N.

CIK 00018210741 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001821074

Recent Transactions

50 trades

Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-09-17$2.08/sh+79,220→ 306,629 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-09-17−42,246→ 27,653 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-09-17−36,974→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-09-17$50.00/sh−79,220→ 227,409 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-31$2.08/sh+25,000→ 226,886 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-03-31−25,000→ 69,899 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03$31.00/sh−1,281→ 201,886 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03$30.33/sh−5,754→ 203,167 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-03-03+30,000→ 208,921 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-03-03+60,000→ 60,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-01-10$2.08/sh+10,000→ 178,921 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-01-10−10,000→ 94,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-27−25,000→ 104,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-06-27$2.08/sh+25,000→ 168,554 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$43.26/sh−255→ 142,351 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$42.39/sh−1,301→ 142,606 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-04$41.41/sh−2,378→ 143,907 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-03-01+31,250→ 146,285 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-03-01+187,500→ 187,500 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-06-02+10,000→ 129,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-06-02$2.08/sh+10,000→ 115,035 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-02$31.40/sh−314→ 104,568 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-02$30.88/sh−1,056→ 104,882 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-03-01+142,500→ 142,500 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2023-03-01+23,750→ 105,938 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-10-21$2.08/sh+10,000→ 81,279 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-10-21−10,000→ 139,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-10-17−10,000→ 149,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-10-17$2.08/sh+10,000→ 71,279 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-05-03−20,000→ 159,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-05-03$2.08/sh+20,000→ 60,814 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-03-01+80,000→ 80,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-03-01+13,300→ 40,814 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-14$2.08/sh+10,000→ 27,514 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-01-14−10,000→ 179,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-12$2.08/sh+15,000→ 32,514 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-01-12−15,000→ 36,974 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-12$51.21/sh−6,427→ 26,087 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-12$52.13/sh−7,151→ 18,936 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2022-01-12$53.27/sh−1,422→ 17,514 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-12-03$53.31/sh−7,713→ 19,801 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-12-03$54.32/sh−1,987→ 17,814 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-12-03$2.08/sh+10,000→ 27,514 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2021-12-03−10,000→ 189,899 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-12-03$55.07/sh−300→ 17,514 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2021-11-23−10,000→ 199,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-11-23$2.08/sh+10,000→ 17,256 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2021-09-03−10,000→ 209,899 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-09-03$2.08/sh−10,000→ 17,256 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2021-09-03$60.05/sh−8,500→ 8,756 total

Companies

Kymera Therapeutics, Inc.
Chief Financial Officer
$KYMR

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov